Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Baseline E(2) levels are higher in BRCA2 mutation carriers: a potential target for prevention?

Cancer causes & control : CCC - 1 Mar 2013

Kim Jayeon, Oktay Kutluk

Abstract excerpt

PURPOSE: BRCA gene mutations and elevated serum estradiol (E(2)) are well-known risk factors for breast cancer. The aim of this study was to investigate the association between BRCA gene mutations and serum E(2) level. METHODS: We measured baseline (menstrual cycle day 2-3) E(2) levels of 96 women with breast cancer who underwent BRCA testing. RESULTS: The mean age, parity, and age at menarche did not differ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms
Share to Estradiol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Menstrual Cycle

Share to Pilot Projects

Source

Open in PubMed Open full text

Identifiers

PMID: 23271408
DOI: 10.1007/s10552-012-0127-3
PMCID: PMC3583585

Genes

BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Baseline E(2) levels are higher in BRCA2 mutation carriers: a potential target for prevention?PMID 23271408Read ↗

Prospective multicenter cohort study of estrogen and insulin-like growth factor system in BRCA mutation carriers.Semantic proximity Read ↗

BRCA 1, 2 mutation and earlier menopause: could BRCA 1,2 be used as predictor of menopause?Semantic proximity Read ↗

The role of estrogens in BRCA1/2 mutation carriers: reflections on the past, issues for the future.Semantic proximity Read ↗

Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.Semantic proximity Read ↗

Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.Semantic proximity Read ↗

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2.Semantic proximity Read ↗

Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes.Semantic proximity Read ↗

High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.Semantic proximity Read ↗

Estrogen and BRCA1 deficiency synergistically induce breast cancer mutation-related DNA damage.Semantic proximity Read ↗

Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.Semantic proximity Read ↗

[Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.